Credits: Canva
Until law, GLP-1 drugs were used to treat diabetes, obesity and even the recent evidences suggest that it could as well be used to treat chronic kidney problems. There is yet another research, published in JAMA Psychiatry on February 25, titled Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial that explores if GLP-1 receptor agonist semaglutide reduce alcohol consumption and cravings in adults with alcohol use disorder.
The research was conducted over a period of 9 weeks, where in the randomized clinical trial, the participants who were administered semaglutide, it led to reductions in some but not all measures of weekly consumptions. It also reduced weekly alcohol and craving related to placebo, and also led to a greater relative reduction in cigarettes per day.
The research also found that weekly injections of semaglutide, which is the active ingredient in weight loss drugs like Wegovy also helped reduce cravings in people with alcohol use disorder.
The lead author Christian Hendershot said that these findings will help in developing new approaches to treat alcoholism. "Two drugs currently approved to reduce alcohol consumption aren't widely used. The popularity of Ozempic and other GLP-1 receptor agonists increases the chances of broad adoption of these treatments for alcohol use disorder," said Hendershot in news release by the University of Southern California's Institute for Addiction Research, where he is the director.
The study is government-funded research and was funded by the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health.
The study was small, and took in account for only 48 adults over two months, thus experts say that it is not yet clear how safe these drugs are for people who do not need to lose weight. Though the results do add up with the evidence form animal studies on drugs like Ozempic and Wegovy on how it helps manage cravings, not just for food, but also for tobacco and alcohol. Scientists are also studying these drugs on smokers, people with opioid addiction and cocaine users.
Co-author Dr Klara Klein of the University of North Carolina at Chapel Hill who treats people with obesity and diabetes said, "This is such promising data. And we need more of it. We frequently will hear that once people start these medications that their desire to drink is very reduced, if not completely abolished."
The GLP-1 receptor agonists work by mimicking hormones GLP-1 in the gut and brain that regulates appetite and feelings of fullness. This response is what helps one lose weight, and what helps one curb their craving for alcohol. These drugs that mimic the functioning of your brain, which is responsible to tell your body when to stop consuming, are the same hormones that tell your body about other kinds of consumptions, including alcohol. Therefore by consuming the weight loss drugs one can treat alcohol use disorder.
However, the researchers have pointed out on the limited data on the research and have suggested to continue using the three approved drugs by the National Institute on Alcohol Abuse and Alcoholism and Substance Abuse and Mental Health Services Administration, namely, Disulfiram, Naltrexone, and Acamprosate to treat alcohol use disorder until large studies confirm these findings.
Credit: AI generated image
The much-awaited 2026 FIFA World Cup is set to begin tonight. The tournament will be hosted by the United States, Canada, and Mexico across 16 cities in the three countries.
The 39-day event kicks off in Mexico on Thursday amid ongoing health outbreaks such as measles, Ebola, and hantavirus.
More than 750,000 soccer fans are expected to travel from over 100 countries to witness 104 matches. The influx of visitors will crowd public transportation, restaurants, and other public spaces, increasing the risk of exposure to infectious diseases, heat-related illnesses, and injuries.
Ahead of the mass gatherings, the Pan American Health Organization (PAHO) has issued new public health recommendations for travelers.
"The celebration happens both inside and outside the stadiums, but to fully enjoy it, it's important to take care of yourself and stay informed," PAHO said.
Check your protection against measles, which is on the rise across the Americas.
Other recommended vaccines include:
A public health team based in Washington, D.C., plans to monitor wastewater and internet activity to detect and track infectious diseases should they emerge in any of the US or Canadian cities hosting World Cup matches, players, and millions of spectators, Reuters reported.
Detecting disease-causing microorganisms in wastewater can provide an early warning of emerging outbreaks, giving health officials time to alert clinicians to watch for symptoms that might otherwise be misdiagnosed and to encourage the public to take preventive measures.
Read More: Confused By Your Cholesterol Report? Here's What LDL And ApoB Really Mean
Beyond infectious diseases, heat is expected to be a major concern during the FIFA World Cup. Host cities such as Houston, Miami, Mexico City and Los Angeles can experience extreme temperatures in June and July, making it dangerous for fans standing outdoors in large crowds for extended periods.
Writing in Forbes, Jesse Pines, an integrative medicine physician at Eterna Integrative and a Clinical Professor at George Washington University (GW), explained that heat exhaustion occurs when the body overheats and loses vital fluids and salts through sweating.
"Warning signs include dizziness, a rapid but weak pulse and cool, clammy skin. Left untreated, it can escalate quickly into heat stroke — a life-threatening emergency that can kill or cause permanent brain damage. Core body temperature above 104 degrees F, confusion and cessation of sweating are the hallmarks," he said.
Pines noted that alcohol can significantly increase the risk of heat-related illness. To reduce the risk, he recommends eating a full meal before drinking, choosing water over alcoholic beverages and keeping electrolyte drinks on hand.
The expert said certain groups may face a higher risk during mass gatherings in summer heat, including:
Credit: iStock
The UK government has confirmed a case of hantavirus infection in Tristan da Cunha, a remote British Overseas Territory in the South Atlantic Ocean, World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus has said.
In a post on social media platform X, Tedros said the patient had previously been classified as a probable case and had been exposed aboard the MV Hondius.
“As of June 10, the total number of confirmed cases remains 13, including three deaths,” he said. “No new deaths have been reported since May 2,” when a cluster of severe respiratory illnesses linked to the Dutch-flagged cruise ship MV Hondius was reported to the WHO.
While the outbreak aboard the luxury vessel had raised concerns about wider transmission. However, the WHO has assessed the overall risk to the public as low. The global health body recommended active health monitoring for all evacuated passengers for 42 days from their last exposure date, either in designated quarantine facilities or at home. The monitoring period is scheduled to continue until June 21.
The outbreak, which claimed three lives and infected 13 people, was driven by the Andes strain, which carries a risk of human-to-human transmission. There is currently no specific antiviral drug or vaccine for the Andes virus.
Also read: Can Hantavirus Spread Through Semen And Breast Milk? What Experts Say
A recent study published in The Lancet Infectious Diseases reported early promising results for tocilizumab as a treatment for severe hantavirus pulmonary syndrome (HPS).
The study is based on a case series involving 10 hantavirus patients treated at Hospital Zonal de Bariloche, Argentina, between June 1, 2024, and May 6, 2026.
Tocilizumab is an immunosuppressive medication used to treat severe inflammatory conditions, including severe COVID-19 and autoimmune diseases such as rheumatoid arthritis.
Researchers from San Carlos de Bariloche, Argentina, said that under an ethical framework allowing the emergency use of unproven medications outside clinical trials when no satisfactory alternatives exist, tocilizumab was administered to five eligible patients with laboratory-confirmed severe hantavirus pulmonary syndrome.
Five other patients received standard supportive care without tocilizumab because they were too sick or the medication was unavailable when treatment was being considered. The researchers said tocilizumab warrants further evaluation as a treatment for severe hantavirus pulmonary syndrome.
According to the WHO, hantaviruses are zoonotic viruses that naturally infect rodents and are occasionally transmitted to humans.
Globally, an estimated 100,000 to 200,000 hantavirus infections occur each year. The majority of these cases are in Asia, particularly China. Most are sporadic or occur in small clusters linked to contact with infected rodents.
Infection in people can result in severe illness and often death, although the diseases vary by type of virus and geographical location.
The WHO has confirmed that the Andes strain of hantavirus—the only strain known to spread from person to person—is responsible for the outbreak. There is currently no vaccine available for the strain.
Notably, the WHO has not specified the type of hantavirus or syndrome involved in the cruise ship incident, but it did mention respiratory risks.
Hantavirus is primarily spread by rodents through:
Credit: AI generated image
Two orphaned babies have died of Ebola in the Democratic Republic of Congo, in an outbreak that could rival the worst on record.
Baby Buswaza was brought to a church-run orphanage in eastern Congo after her mother died in late May. The newborn was running a fever and, within days, died from what was later found to be Ebola, Reuters reported.
Buswaza was buried in late May in a sealed, waterproof body bag to prevent the spread of the disease.
Six more babies have been identified as suspected Ebola cases at the orphanage of 69 children in Bunia, a city in Ituri province at the epicentre of the outbreak in Congo.
They were taken to hospital, where five of them later tested negative and were discharged from an isolation tent at the Evangelical Medical Centre (CME) by medics.
Another baby—an orphaned triplet girl nicknamed "Cherie" or "darling" who was less than a year old—with confirmed Ebola died on June 10, Dr. Freddy Kibwana, head of the CME, told Reuters. "The child has left us," he said.
Children and babies can easily become vectors for the disease through bodily fluids like vomit, faeces and saliva, which are highly infectious when people have Ebola.
"This epidemic has hit an area already in humanitarian crisis," said Babou Rukengeza, a senior health adviser with Save the Children aid group. "This place is the only refuge for these children."
“This outbreak is moving at a terrifying speed. I have responded to several Ebola outbreaks over the years, but this is the fastest spread I have ever seen. Children are paying a devastating price," he added.
The expert noted that “when parents die, children suddenly lose the biggest support system they could possibly have and face fear, grief, stigma, and social exclusion".
In addition to fluids like blood and saliva, Ebola has also been detected in amniotic fluid and the placenta, as per the World Health Organization, so it is possible Buswaza's mother transmitted the virus to her in the womb or during childbirth.
If the mother caught the virus after giving birth, she may also have transmitted it to her child through breastmilk, where the virus has also been detected.
According to the US CDC, the confirmed cases in Congo have risen to 635, while there are 127 confirmed deaths. In Uganda, there are 19 confirmed cases and two confirmed deaths, along with one probable case and one probable death.
Using genetic fingerprinting, the illnesses have been identified as Bundibugyo virus, one of the four types of orthoebolaviruses that cause Ebola disease in people. There is no vaccine for Bundibugyo virus, and treatment consists of supportive care.
Meanwhile, the WHO has revised the risk assessment in Congo and Uganda. The risk has been revised to “very high at the national level in DRC and high for Uganda,” the WHO said.
It is also high for countries sharing land borders with DRC and Uganda, while low for the rest of the Africa region and at the global level.
The WHO explained that the risk in DRC remains very high because “the outbreak has continued to expand rapidly in terms of numbers of cases and geographical spread with more areas affected. Epidemiological links and the full chain of transmission are not yet clearly established, and the source of the outbreak remains under investigation”.
Moreover, the ongoing conflict is restricting movement of frontline responders and surveillance teams, while community fear and misinformation are hindering case detection, contact tracing and isolation, and potentially facilitating disease spread.
There are also other challenges such as limited healthcare infrastructure and delays in laboratory confirmation, although these are being scaled up by DRC with support from partners, the WHO said.
© 2024 Bennett, Coleman & Company Limited